Tag: GLP-1 import ban
Import Alerts: How the FDA Blocks Drugs from Non-Compliant Manufacturers
The FDA uses Import Alerts to block drugs from non-compliant manufacturers, automatically detaining shipments without inspection. Learn how the Green List works, why Indian and Chinese suppliers are being targeted, and what manufacturers must do to stay in the U.S. market.
view morerecent posts
Switching from an originator biologic to a biosimilar is safe for most patients with stable autoimmune conditions. Learn what really happens during the switch, why some people stop treatment, and how to make the transition work for you.
Published ON: 17 DecTravel insurance can cover emergency medications abroad - but not your regular prescriptions. Learn what’s included, how to file claims, and which providers actually deliver when you need them most.
Published ON: 4 DecCommunity health presentations are helping patients understand that generic drugs are just as safe and effective as brand-name medications-saving billions and improving adherence. Learn how public education is breaking down myths and expanding access.
Published ON: 1 DecThe FDA issues warning letters to manufacturers who violate safety and labeling laws. These letters are the first step in enforcement that can lead to recalls, fines, or criminal charges. Learn how the agency targets non-compliant companies and what you must do to avoid serious consequences.
Published ON: 1 DecChronic Alcohol Use Disorder affects millions and carries serious health risks-from liver damage to cancer and brain changes. Effective treatments exist, including medications, therapy, and support groups. Recovery is possible with the right help.
Published ON: 1 Dec